Cargando…

Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study

BACKGROUND: Lactate is a robust prognostic marker for the outcome of critically ill patients. Several small studies reported that metformin users have higher lactate levels at ICU admission without a concomitant increase in mortality. However, this has not been investigated in a larger cohort. We ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Posma, Rene A., Frøslev, Trine, Jespersen, Bente, van der Horst, Iwan C. C., Touw, Daan J., Thomsen, Reimar W., Nijsten, Maarten W., Christiansen, Christian F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098407/
https://www.ncbi.nlm.nih.gov/pubmed/32219580
http://dx.doi.org/10.1186/s13613-020-00652-0
_version_ 1783511175101677568
author Posma, Rene A.
Frøslev, Trine
Jespersen, Bente
van der Horst, Iwan C. C.
Touw, Daan J.
Thomsen, Reimar W.
Nijsten, Maarten W.
Christiansen, Christian F.
author_facet Posma, Rene A.
Frøslev, Trine
Jespersen, Bente
van der Horst, Iwan C. C.
Touw, Daan J.
Thomsen, Reimar W.
Nijsten, Maarten W.
Christiansen, Christian F.
author_sort Posma, Rene A.
collection PubMed
description BACKGROUND: Lactate is a robust prognostic marker for the outcome of critically ill patients. Several small studies reported that metformin users have higher lactate levels at ICU admission without a concomitant increase in mortality. However, this has not been investigated in a larger cohort. We aimed to determine whether the association between lactate levels around ICU admission and mortality is different in metformin users compared to metformin nonusers. METHODS: This cohort study included patients admitted to ICUs in northern Denmark between January 2010 and August 2017 with any circulating lactate measured around ICU admission, which was defined as 12 h before until 6 h after admission. The association between the mean of the lactate levels measured during this period and 30-day mortality was determined for metformin users and nonusers by modelling restricted cubic splines obtained from a Cox regression model. RESULTS: Of 37,293 included patients, 3183 (9%) used metformin. The median (interquartile range) lactate level was 1.8 (1.2–3.2) in metformin users and 1.6 (1.0–2.7) mmol/L in metformin nonusers. Lactate levels were strongly associated with mortality for both metformin users and nonusers. However, the association of lactate with mortality was different for metformin users, with a lower mortality rate in metformin users than in nonusers when admitted with similar lactate levels. This was observed over the whole range of lactate levels, and consequently, the relation of lactate with mortality was shifted rightwards for metformin users. CONCLUSION: In this large observational cohort of critically ill patients, early lactate levels were strongly associated with mortality. Irrespective of the degree of hyperlactataemia, similar lactate levels were associated with a lower mortality rate in metformin users compared with metformin nonusers. Therefore, lactate levels around ICU admission should be interpreted according to metformin use.
format Online
Article
Text
id pubmed-7098407
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-70984072020-03-30 Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study Posma, Rene A. Frøslev, Trine Jespersen, Bente van der Horst, Iwan C. C. Touw, Daan J. Thomsen, Reimar W. Nijsten, Maarten W. Christiansen, Christian F. Ann Intensive Care Research BACKGROUND: Lactate is a robust prognostic marker for the outcome of critically ill patients. Several small studies reported that metformin users have higher lactate levels at ICU admission without a concomitant increase in mortality. However, this has not been investigated in a larger cohort. We aimed to determine whether the association between lactate levels around ICU admission and mortality is different in metformin users compared to metformin nonusers. METHODS: This cohort study included patients admitted to ICUs in northern Denmark between January 2010 and August 2017 with any circulating lactate measured around ICU admission, which was defined as 12 h before until 6 h after admission. The association between the mean of the lactate levels measured during this period and 30-day mortality was determined for metformin users and nonusers by modelling restricted cubic splines obtained from a Cox regression model. RESULTS: Of 37,293 included patients, 3183 (9%) used metformin. The median (interquartile range) lactate level was 1.8 (1.2–3.2) in metformin users and 1.6 (1.0–2.7) mmol/L in metformin nonusers. Lactate levels were strongly associated with mortality for both metformin users and nonusers. However, the association of lactate with mortality was different for metformin users, with a lower mortality rate in metformin users than in nonusers when admitted with similar lactate levels. This was observed over the whole range of lactate levels, and consequently, the relation of lactate with mortality was shifted rightwards for metformin users. CONCLUSION: In this large observational cohort of critically ill patients, early lactate levels were strongly associated with mortality. Irrespective of the degree of hyperlactataemia, similar lactate levels were associated with a lower mortality rate in metformin users compared with metformin nonusers. Therefore, lactate levels around ICU admission should be interpreted according to metformin use. Springer International Publishing 2020-03-26 /pmc/articles/PMC7098407/ /pubmed/32219580 http://dx.doi.org/10.1186/s13613-020-00652-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Research
Posma, Rene A.
Frøslev, Trine
Jespersen, Bente
van der Horst, Iwan C. C.
Touw, Daan J.
Thomsen, Reimar W.
Nijsten, Maarten W.
Christiansen, Christian F.
Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study
title Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study
title_full Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study
title_fullStr Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study
title_full_unstemmed Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study
title_short Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study
title_sort prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a danish registry-based cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098407/
https://www.ncbi.nlm.nih.gov/pubmed/32219580
http://dx.doi.org/10.1186/s13613-020-00652-0
work_keys_str_mv AT posmarenea prognosticimpactofelevatedlactatelevelsonmortalityincriticallyillpatientswithandwithoutpreadmissionmetformintreatmentadanishregistrybasedcohortstudy
AT frøslevtrine prognosticimpactofelevatedlactatelevelsonmortalityincriticallyillpatientswithandwithoutpreadmissionmetformintreatmentadanishregistrybasedcohortstudy
AT jespersenbente prognosticimpactofelevatedlactatelevelsonmortalityincriticallyillpatientswithandwithoutpreadmissionmetformintreatmentadanishregistrybasedcohortstudy
AT vanderhorstiwancc prognosticimpactofelevatedlactatelevelsonmortalityincriticallyillpatientswithandwithoutpreadmissionmetformintreatmentadanishregistrybasedcohortstudy
AT touwdaanj prognosticimpactofelevatedlactatelevelsonmortalityincriticallyillpatientswithandwithoutpreadmissionmetformintreatmentadanishregistrybasedcohortstudy
AT thomsenreimarw prognosticimpactofelevatedlactatelevelsonmortalityincriticallyillpatientswithandwithoutpreadmissionmetformintreatmentadanishregistrybasedcohortstudy
AT nijstenmaartenw prognosticimpactofelevatedlactatelevelsonmortalityincriticallyillpatientswithandwithoutpreadmissionmetformintreatmentadanishregistrybasedcohortstudy
AT christiansenchristianf prognosticimpactofelevatedlactatelevelsonmortalityincriticallyillpatientswithandwithoutpreadmissionmetformintreatmentadanishregistrybasedcohortstudy